We recently reported mouse models of prostate cancer that recapitulate the most frequent ETS gene fusions, TMPRSS2-ERG and TMPRSS2-ETV1, with ectopic ERG or ETV1 expression from the endogenous Tmprss2 promoter [9]. This evidence concerns the gene ERG and prostate carcinoma.